AdaptX
PrivateLast Round
Series A
Extension
Nov 1, 2023
Est. Valuation
$26.37M
Total Funding Raised
$19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AdaptX operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series A Extension round in November 2023.
AdaptX is a health technology company that provides an AI-driven clinical management platform enabling health systems to analyze real-world electronic medical record data to improve clinical performance, capacity, and patient outcomes.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, EHR & EMR, Medical AI, Business Intelligence, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AdaptX Comparables
Compare AdaptX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EvidenceCare | 78% | |
| RLDatix | 74% | |
| Innovaccer | 71% |
For institutional investors. Book with your work email.
AdaptX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 1, 2023 | ||||
| Series A | Jul 28, 2021 | ||||
| VC Round | May 25, 2020 | ||||
| Seed | May 14, 2019 |
For institutional investors. Book with your work email.
AdaptX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders' Co-op | VC Round, Series A Extension, Series A, Seed |
| WRF Capital | Seed, Series A Extension, Series A |
| Morningside Ventures | Series A Extension |
| Vulcan Capital | VC Round, Series A |
| Washington Research Foundation Capital | VC Round, Seed, Series A Extension, Series A |
| Cercano Management | Series A Extension, Series A |
| Fortson Venture Capital | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 35% MoM, reaching 2.2K.
- Jul 27, 2026
Monthly visitors grew 48% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
AdaptX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AdaptX's valuation, stock price, and market status.
Is AdaptX a public or private company?
AdaptX is a private company.
What is the current stock price of AdaptX?
AdaptX is a private company, so its shares have no public market price. Caplight tracks AdaptX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AdaptX worth (valuation)?
AdaptX's valuation is estimated at $26.4M based on funding round data.
Can I buy AdaptX stock?
AdaptX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AdaptX's last funding round?
AdaptX's most recent funding round was Series A Extension on November 1, 2023.
Who are the main investors in AdaptX?
Key investors in AdaptX include Founders' Co-op, Vulcan Capital, Cercano Management.
Will AdaptX IPO soon?
No public IPO plans have been announced for AdaptX.
How can I track AdaptX secondary market activity?
Caplight tracks bids, offers, and trades in AdaptX's shares on secondary markets.